176 related articles for article (PubMed ID: 36789106)
41. HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE).
Zhou H; Jin C; Cui L; Xing H; Liu J; Liao W; Liao H; Yu Y
J Cell Physiol; 2018 Sep; 233(9):6714-6721. PubMed ID: 29215715
[TBL] [Abstract][Full Text] [Related]
42. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
[TBL] [Abstract][Full Text] [Related]
43. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
44. GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival.
Sette P; Amankulor N; Li A; Marzulli M; Leronni D; Zhang M; Goins WF; Kaur B; Bolyard C; Cripe TP; Yu J; Chiocca EA; Glorioso JC; Grandi P
Mol Ther Oncolytics; 2019 Dec; 15():214-222. PubMed ID: 31890868
[TBL] [Abstract][Full Text] [Related]
45. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
Ge X; Arriazu E; Magdaleno F; Antoine DJ; Dela Cruz R; Theise N; Nieto N
Hepatology; 2018 Dec; 68(6):2380-2404. PubMed ID: 29774570
[TBL] [Abstract][Full Text] [Related]
46. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.
Lin L; Zhong K; Sun Z; Wu G; Ding G
J Cancer Res Clin Oncol; 2012 Jan; 138(1):11-22. PubMed ID: 21947243
[TBL] [Abstract][Full Text] [Related]
47. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients.
Watanabe T; Asai K; Fujimoto H; Tanaka H; Kanazawa H; Hirata K
Respir Med; 2011 Apr; 105(4):519-25. PubMed ID: 21041074
[TBL] [Abstract][Full Text] [Related]
48. Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis.
Liu XY; Li HL; Su JB; Ding FH; Zhao JJ; Chai F; Li YX; Cui SC; Sun FY; Wu ZY; Xu P; Chen XH
J Neurochem; 2015 Apr; 133(2):187-98. PubMed ID: 25689357
[TBL] [Abstract][Full Text] [Related]
49. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
50. Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing.
Tadié JM; Bae HB; Banerjee S; Zmijewski JW; Abraham E
Am J Physiol Cell Physiol; 2012 Jan; 302(1):C249-56. PubMed ID: 22012330
[TBL] [Abstract][Full Text] [Related]
51. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Ren L; Lou Y; Sun M
Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479
[TBL] [Abstract][Full Text] [Related]
52. Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy.
Ning J; Wakimoto H
Front Microbiol; 2014; 5():303. PubMed ID: 24999342
[TBL] [Abstract][Full Text] [Related]
53. Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.
Tamura K; Wakimoto H; Agarwal AS; Rabkin SD; Bhere D; Martuza RL; Kuroda T; Kasmieh R; Shah K
Mol Ther; 2013 Jan; 21(1):68-77. PubMed ID: 22929661
[TBL] [Abstract][Full Text] [Related]
54. Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis.
Yang G; Huang Y; Wu X; Lin X; Xu J; Chen X; Bai X; Li Q
Biomed Res Int; 2018; 2018():8216578. PubMed ID: 29850572
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation.
Tancharoen S; Tengrungsun T; Suddhasthira T; Kikuchi K; Vechvongvan N; Tokuda M; Maruyama I
Mediators Inflamm; 2014; 2014():754069. PubMed ID: 25114379
[TBL] [Abstract][Full Text] [Related]
56. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
[TBL] [Abstract][Full Text] [Related]
57. Subendothelial Matrix Stiffening by Lysyl Oxidase Enhances RAGE-Mediated Retinal Endothelial Activation in Diabetes.
Chandrakumar S; Santiago Tierno I; Agarwal M; Matisioudis N; Kern TS; Ghosh K
Diabetes; 2023 Jul; 72(7):973-985. PubMed ID: 37058096
[TBL] [Abstract][Full Text] [Related]
58. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.
Sharma AK; LaPar DJ; Stone ML; Zhao Y; Kron IL; Laubach VE
Am J Transplant; 2013 Sep; 13(9):2255-67. PubMed ID: 23865790
[TBL] [Abstract][Full Text] [Related]
59. Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.
Yoo JY; Pradarelli J; Haseley A; Wojton J; Kaka A; Bratasz A; Alvarez-Breckenridge CA; Yu JG; Powell K; Mazar AP; Teknos TN; Chiocca EA; Glorioso JC; Old M; Kaur B
Clin Cancer Res; 2012 Sep; 18(18):4931-41. PubMed ID: 22753591
[TBL] [Abstract][Full Text] [Related]
60. Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD-like Receptor Family Pyrin Domain-Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes the Progression of Atherosclerosis in ApoE
Tan H; Hu J; Zuo W; Huang Y; Cui J; Gong F; Bai W
J Am Heart Assoc; 2023 Apr; 12(8):e024397. PubMed ID: 37026550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
